Olopatadine Hydrochloride (Sandoz Inc)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Sandoz Inc. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Sandoz Inc |
| NON-PROPRIETARY NAME: | Olopatadine Hydrochloride |
| SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2007-02-15 |
| END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Olopatadine Hydrochloride from Sandoz Inc |
| LABELER NAME: | Sandoz Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 2007-02-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61314-272_edb2a469-db04-4f9c-b221-f821ef9e70e3 |
| PRODUCT NDC: | 61314-272 |
| APPLICATION NUMBER: | NDA021545 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
